| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/10/2002 | CA2413237A1 Alteration of cell membrane for new functions |
| 01/10/2002 | CA2413186A1 Extracellular matrix and cell adhesion molecules |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2413128A1 Transporters and ion channels |
| 01/10/2002 | CA2412882A1 Peptide extended glycosylated polypeptides |
| 01/10/2002 | CA2412872A1 Protein modification and maintenance molecules |
| 01/10/2002 | CA2412775A1 Antibodies to human mcp-1 |
| 01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | CA2410953A1 Adenylyl and guanylyl cyclases |
| 01/10/2002 | CA2410679A1 Secretion and trafficking molecules |
| 01/10/2002 | CA2407910A1 Antibodies that immunospecifically bind to blys |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170380A2 Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170301A1 Process of preparation of peptides and N-carbamoyl protected peptides |
| 01/09/2002 | EP1170300A1 Method for modification of recombinant polypeptides |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169461A2 Production of pancreatic procarboxy-peptidase b, isoforms and muteins thereof, and their use |
| 01/09/2002 | EP1169460A2 Preparation of biologically active molecules |
| 01/09/2002 | EP1169459A1 Dsp-9 dual-specificity map kinase phosphatase |
| 01/09/2002 | EP1169456A1 Recombinant toxin a/toxin b vaccine against clostridium difficile |
| 01/09/2002 | EP1169455A1 Compounds and methods for the diagnosis and treatment of babesia microti infection |
| 01/09/2002 | EP1169451A2 Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes |
| 01/09/2002 | EP1169448A1 Tumor necrosis factor homologs and nucleic acids encoding the same |
| 01/09/2002 | EP1169447A1 Genes and expression products from hematopoietic cells |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169437A1 Noninvasive detection of colorectal cancer and other gastrointestinal pathology |
| 01/09/2002 | EP1169353A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
| 01/09/2002 | EP1169352A1 Erythropoietin receptor antibodies |
| 01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
| 01/09/2002 | EP1169348A1 Purposeful movement of human migratory cells away from an agent source |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169282A1 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor |
| 01/09/2002 | EP1169058A1 Insulin-like growth factor binding protein-4 protease |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1073463A4 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 01/09/2002 | EP0959907A4 The butyrophilin gene promoter and uses thereof |
| 01/09/2002 | EP0873354A4 Novel amp activated protein kinase |
| 01/09/2002 | EP0789764B1 A novel family of protease inhibitors, and other biologic active substances |
| 01/09/2002 | EP0714444B1 Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies |
| 01/09/2002 | EP0495811B1 Production of genetically-engineered vaccines for aids and other retroviral diseases |
| 01/09/2002 | CN1330717A Transformation system in field of flamentrous fungel hosts in chrysosporium |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330665A Multiple domain glycoprotein hormones and methods of using |
| 01/09/2002 | CN1330664A Platelet-derived growth factor C, DNA coding therefor and uses thereof |
| 01/09/2002 | CN1330660A Cycle tetrapeptide compound and their use |
| 01/09/2002 | CN1330555A Antibodies to truncated VEGF-D and uses thereof |
| 01/09/2002 | CN1077438C Recombinant coccidiosis vaccines |
| 01/09/2002 | CN1077410C Process for preparing protein hydrolysate from protein-containing animal products |
| 01/08/2002 | US6337392 Lens transcriptional control elements and methods of use thereof |
| 01/08/2002 | US6337195 A polypeptide for use as a diagnositic marker for colon cancer |
| 01/08/2002 | US6337194 Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin A and B chains |
| 01/08/2002 | CA2118113C Oil-body proteins as carriers of high-value peptides in plants |
| 01/08/2002 | CA2021594C Antibody to human interleukin-6 receptor |
| 01/08/2002 | CA2019559C Bispecific and oligospecific mono- and oligovalent receptors, the preparation and use thereof |
| 01/08/2002 | CA1341332C Method for obtaining protective antigens against bordetella infections and toxic processes |
| 01/03/2002 | WO2002000914A2 Bioengineered vehicles for targeted nucleic acid delivery |
| 01/03/2002 | WO2002000913A2 MODULATION OF β-AMYLOID LEVELS BY β-SECRETASE BACE2 |
| 01/03/2002 | WO2002000892A1 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
| 01/03/2002 | WO2002000885A2 Assembly of wild-type and chimeric influenza virus-like particles (vlps) |
| 01/03/2002 | WO2002000879A2 Methods for producing modified glycoproteins |
| 01/03/2002 | WO2002000876A1 Truncated egf receptor |
| 01/03/2002 | WO2002000856A2 Protein glycosylation modification in pichia pastoris |
| 01/03/2002 | WO2002000840A2 Human lyases |
| 01/03/2002 | WO2002000730A2 Pd-l2 molecules: novel pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000727A2 Gp286 nucleic acids and polypeptides |
| 01/03/2002 | WO2002000724A2 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 01/03/2002 | WO2002000721A2 Cytokine receptor zcytor17 |
| 01/03/2002 | WO2002000715A2 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | WO2002000710A2 B7-like molecules and uses thereof |
| 01/03/2002 | WO2002000692A2 Pd-l2 molecules: pd-1 ligands and uses therefor |
| 01/03/2002 | WO2002000691A2 Polynucleotides and polypeptides encoded thereby |
| 01/03/2002 | WO2002000690A2 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | WO2002000677A1 Nucleic acids, proteins, and antibodies |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001058472A3 Botulinum toxin pharmaceutical compositions |
| 01/03/2002 | WO2001055336A3 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001049839A3 Method for expressing gene and use thereof |
| 01/03/2002 | WO2001049713A3 Stabilizing peptides, polypeptides and antibodies which include them |
| 01/03/2002 | WO2001046383A3 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 01/03/2002 | US20020002273 Rapamycin assay |
| 01/03/2002 | US20020002271 Separating immunoglobulin from mixture; load sample onto chromatographic apparatus, elute immunoglobulin |
| 01/03/2002 | US20020002270 Purified antigen for alzheimer's disease, and methods of obtaining and using same |
| 01/03/2002 | US20020001824 Ligand-gated anion channels of insects |
| 01/03/2002 | US20020001798 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 01/03/2002 | CA2648051A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2648046A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| 01/03/2002 | CA2413747A1 Mammal 2p domain mechano-sensitive k+ channel, cloning and applications thereof |
| 01/03/2002 | CA2413673A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |